Identification of new biomarkers of pyridoxine-dependent epilepsy by GC/MS-based urine metabolomics

被引:20
|
作者
Kuhara, Tomiko [1 ]
Akiyama, Tomoyuki [2 ]
Ohse, Morimasa [1 ]
Koike, Takayoshi [3 ]
Shibasaki, Jun [4 ]
Imai, Katsumi [3 ]
Cooper, Arthur J. L. [5 ]
机构
[1] Japan Clin Metabol Inst, Kahoku, Ishikawa 9291174, Japan
[2] Okayama Univ Hosp, Dept Child Neurol, Okayama 7008558, Japan
[3] NHO Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Dept Pediat, Shizuoka 4208688, Japan
[4] Kanagawa Childrens Med Ctr, Dept Neonatol, Yokohama, Kanagawa 2328555, Japan
[5] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA
关键词
Delta(2)-Piperideine-6-carboxylate; 6-Oxopipecolate; Metabolomics; Gas chromatography-mass spectrometry; Biomarker; Pipecolate; ALPHA-AMINOADIPIC SEMIALDEHYDE; L-PIPECOLATE OXIDASE; INBORN-ERRORS; ISOTOPE-DILUTION; 6-OXO-PIPERIDINE-2-CARBOXYLIC ACID; MASS-SPECTROMETRY; HUMAN-LIVER; DIAGNOSIS; DEFICIENCY; METABOLISM;
D O I
10.1016/j.ab.2020.113739
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Aminoadipic semialdehyde and its cyclic form (Delta(2)-piperideine-6-carboxylate) accumulate in patients with alpha-aminoadipic semialdehyde dehydrogenase (AASADH; antiquitin; ALDH7A1) deficiency. Delta(1) -Piperideine-6-carboxylate is known to react with pyridoxal 5'-phosphate (PLP) to form a Knoevenagel condensation product, resulting in pyridoxine-dependent epilepsy. Despite dramatic clinical improvement following pyridoxine supplementation, many patients still suffer some degree of intellectual disability due to delayed diagnosis. In order to expedite the diagnosis of patients with suspected AASADH deficiency and minimize the delay in treatment, we used gas chromatography-mass spectrometry-based metabolomics to search for potentially diagnostic biomarkers in urine from four patients with ALDH7A1 mutations, and identified Delta(2)-piperideine-6-carboxylate, 6-oxopipecolate, and pipecolate as candidate biomarkers. In a patient at postnatal day six, but before pyridoxine treatment, Delta(2)-piperideine-6-carboxylate and pipecolate were present at very high concentrations, indicating that these compounds may be good biomarkers for untreated AASADH deficiency patients. On the other hand, following pyridoxine/PLP treatment, 6-oxopipecolate was shown to be greatly elevated. We suggest that noninvasive urine metabolomics screening for Delta(2)-piperideine-6-carboxylate, 6-oxopipecolate, and pipecolate will be useful for prompt and reliable diagnosis of AASADH deficiency in patients within any age group. The most appropriate combination among Delta(2)-piperideine-6-carboxylate, 6-oxopipecolate, and pipecolate as biomarkers for AASADH deficiency patients appears to depend on the age of the patient and whether pyridoxine/PLP supplementation has been implemented. We anticipate that the present bioanalytical information will also be useful to researchers studying glutamate, proline, lysine and ornithine metabolism in mammals and other organisms.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy
    Engelke, Udo F. H.
    van Outersterp, Rianne E.
    Merx, Jona
    van Geenen, Fred A. M. G.
    van Rooij, Arno
    Berden, Giel
    Huigen, Marleen C. D. G.
    Kluijtmans, Leo A. J.
    Peters, Tessa M. A.
    Al-Shekaili, Hilal H.
    Leavitt, Blair R.
    de Vrieze, Erik
    Broekman, Sanne
    van Wijk, Erwin
    Tseng, Laura A.
    Kulkarni, Purva
    Rutjes, Floris P. J. T.
    Mecinovic, Jasmin
    Struys, Eduard A.
    Jansen, Laura A.
    Gospe, Sidney M., Jr.
    Mercimek-Andrews, Saadet
    Hyland, Keith
    Willemsen, Michel A. A. P.
    Bok, Levinus A.
    van Karnebeek, Clara D. M.
    Wevers, Ron A.
    Boltje, Thomas J.
    Oomens, Jos
    Martens, Jonathan
    Coene, Karlien L. M.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (15):
  • [2] Identification of antifungal quinolizidines using GC/MS-based metabolomics
    Cely-Veloza, W.
    Coy-Barrera, E.
    PLANTA MEDICA, 2019, 85 (18) : 1462 - 1462
  • [3] Biomarkers Aiding Diagnosis of Atypical Presentation of Pyridoxine-Dependent Epilepsy
    Segal, Eric B.
    Grinspan, Zachary M.
    Mandel, Arthur M.
    Gospe, Sidney M., Jr.
    PEDIATRIC NEUROLOGY, 2011, 44 (04) : 289 - 291
  • [4] Metabolite Identification Using Infrared Ion Spectroscopy-Novel Biomarkers for Pyridoxine-Dependent Epilepsy
    van Outersterp, Rianne E.
    Engelke, Udo F. H.
    Merx, Jona
    Berden, Giel
    Paul, Mathias
    Thomulka, Thomas
    Berkessel, Albrecht
    Huigen, Marleen C. D. G.
    Kluijtmans, Leo A. J.
    Mecinovic, Jasmin
    Rutjes, Floris P. J. T.
    van Karnebeek, Clara D. M.
    Wevers, Ron A.
    Boltje, Thomas J.
    Coene, Karlien L. M.
    Martens, Jonathan
    Oomens, Jos
    ANALYTICAL CHEMISTRY, 2021, 93 (46) : 15340 - 15348
  • [5] PYRIDOXINE-DEPENDENT EPILEPSY - NEW OBSERVATIONS AND CLINICAL SPECTRUM
    TREVATHAN, E
    MIKATI, M
    KRISHNAMOORTHY, KS
    LOMBROSO, CT
    ANNALS OF NEUROLOGY, 1987, 22 (03) : 437 - 437
  • [6] GC/MS-based urine metabolomics analysis of renal allograft recipients with acute rejection
    Long Zheng
    Jina Wang
    Wenjun Gao
    Chao Hu
    Shuo Wang
    Ruiming Rong
    Yinlong Guo
    Tongyu Zhu
    Dong Zhu
    Journal of Translational Medicine, 16
  • [7] GC/MS-based urine metabolomics analysis of renal allograft recipients with acute rejection
    Zheng, Long
    Wang, Jina
    Gao, Wenjun
    Hu, Chao
    Wang, Shuo
    Rong, Ruiming
    Guo, Yinlong
    Zhu, Tongyu
    Zhu, Dong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [8] Global Metabolomics Discovers Two Novel Biomarkers in Pyridoxine-Dependent Epilepsy Caused by ALDH7A1 Deficiency
    Bohm, Hans-Otto
    Yazdani, Mazyar
    Sandas, Elise Mork
    Vassli, Anja Osteby
    Kristensen, Erle
    Rootwelt, Helge
    Skogvold, Hanne Bendiksen
    Brodtkorb, Eylert
    Elgstoen, Katja Benedikte Presto
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [9] Hydrocephalus in pyridoxine-dependent epilepsy: New case and literature review
    Navarro-Abia, Virginia
    Soriano-Ramos, Maria
    Nunez-Enamorado, Noemi
    Camacho-Salas, Ana
    Martinez-de Aragon, Ana
    Martin-Hernandez, Elena
    Simon-de las Heras, Rogelio
    BRAIN & DEVELOPMENT, 2018, 40 (04): : 348 - 352
  • [10] Identification of a novel biomarker for pyridoxine-dependent epilepsy: Implications for newborn screening
    Wempe, Michael F.
    Kumar, Amit
    Kumar, Vijay
    Choi, Yu J.
    Swanson, Michael A.
    Friederich, Marisa W.
    Hyland, Keith
    Yue, Wyatt W.
    Van Hove, Johan L. K.
    Coughlin, Curtis R., II
    JOURNAL OF INHERITED METABOLIC DISEASE, 2019, 42 (03) : 565 - 574